These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4076844)

  • 1. Platelet adhesion in hyperlipidemic and hypertensive patients.
    Brook JG; Marmur A; Berkovitch Y; Aviram M
    Haemostasis; 1985; 15(6):371-6. PubMed ID: 4076844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.
    Markel A; Brook JG; Levy Y; Aviram M; Youdim MB
    Br J Clin Pharmacol; 1983 Dec; 16(6):663-8. PubMed ID: 6661351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
    Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A
    Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemia.
    Joist JH; Baker RK; Schonfeld G
    Thromb Res; 1979; 15(1-2):95-108. PubMed ID: 314689
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
    Epstein SE; LUbbe WF
    S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
    Telatyńska-Smieszek B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
    Pol Arch Med Wewn; 2004 Jan; 111(1):45-51. PubMed ID: 15088420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atenolol and propanolol on platelet aggregation in moderate essential hypertension.
    Beyan C; Kaptan K; Ifran A
    Croat Med J; 2005 Aug; 46(4):695-6; author reply 696-7. PubMed ID: 16161254
    [No Abstract]   [Full Text] [Related]  

  • 8. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
    Rizos E; Bairaktari E; Kostoula A; Hasiotis G; Achimastos A; Ganotakis E; Elisaf M; Mikhailidis DP
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):127-34. PubMed ID: 12808486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
    González-Gómez A; García-Barreto D; Gamio Capestany F; Hernández-Cañero A; Fong Chi S
    Cor Vasa; 1982; 24(6):422-8. PubMed ID: 6764167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension.
    Aberg H; Hedstrand H; Wetterberg L; Ross SB
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):15-8. PubMed ID: 1150360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of some beta-blocking drugs on plasma renin activity, platelet adhesiveness and dilute blood clot lysis time in patients with essential arterial hypertension.
    Vlaicu R; Uza G; Mărcuş C; Voinescu I
    Med Interne; 1980; 18(3):247-51. PubMed ID: 6106281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic modification of aortic atherosclerosis. Effects of propranolol vs hydralazine in hypertensive hyperlipidemic rabbits.
    Spence JD; Perkins DG; Kline RL; Adams MA; Haust MD
    Atherosclerosis; 1984 Mar; 50(3):325-33. PubMed ID: 6712777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
    Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.
    Savoia C; Touyz RM; Amiri F; Schiffrin EL
    Hypertension; 2008 Feb; 51(2):432-9. PubMed ID: 18195160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial].
    Witchitz S; Provendier O; Arsenescu I
    Presse Med; 1996 Dec; 25(40):2013-6. PubMed ID: 9082374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
    Steiner SS; Friedhoff AJ; Wilson BL; Wecker JR; Santo JP
    J Hum Hypertens; 1990 Jun; 4(3):217-25. PubMed ID: 2194029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.